The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation.
about
The influence of UGT polymorphisms as biomarkers in solid organ transplantationAssociation of mycophenolic acid dose with efficacy and safety events in kidney transplant patients receiving tacrolimus: an analysis of the Mycophenolic acid Observational REnal transplant registry.Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity study.Evaluation of potential interactions between mycophenolic acid derivatives and proton pump inhibitors.Current pharmacotherapeutical options for the prevention of kidney transplant rejection.Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?Mycophenolate revisited.Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients.Therapeutic drug monitoring of mycophenolate in adult solid organ transplant patients: an update.An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantationThe optimal MMF dose in tacrolimus treated patients.Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers.The efficacy and safety of intensified enteric-coated mycophenolate sodium with low exposure of calcineurin inhibitors in Chinese de novo kidney transplant recipients: a prospective study.
P2860
Q27009825-6BAC4C31-531B-4153-A54A-5A7E0E05E2A8Q36566866-911F1535-8516-47D0-93A5-B1ECE1EC1D2BQ37651129-43CD798D-4030-49EE-AEB0-950D6035802BQ38027466-4509EE73-F6BC-4BAB-AEA2-E69CF38E7A48Q38096463-93FD27AF-8F16-4D8C-B784-A6A939FDA0BFQ38208983-35EE585A-5257-4BB3-A354-D05865D37280Q38223136-0F35C541-58E1-4B8B-A60C-3AF42991C861Q38373106-0C5A8E29-12F4-4BFF-8C4D-8768E4662277Q38417581-5AAC7641-C085-4001-8BC5-49FDE1AF6B43Q38791599-68DEA562-7677-49ED-9385-88A1E5238E10Q41015774-E0477D08-6658-42DE-AA8D-D241373DF4E9Q44083192-54600F05-3CD6-41E2-9C70-2CFA05F3CBF8Q48157905-B5731406-BC79-4D4E-B9AD-B09A96EA185FQ53607269-DF9B357C-3ECC-4CB2-BED6-AA342F730023
P2860
The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The CLEAR study: a 5-day, 3-g ...... sing in renal transplantation.
@ast
The CLEAR study: a 5-day, 3-g ...... sing in renal transplantation.
@en
type
label
The CLEAR study: a 5-day, 3-g ...... sing in renal transplantation.
@ast
The CLEAR study: a 5-day, 3-g ...... sing in renal transplantation.
@en
prefLabel
The CLEAR study: a 5-day, 3-g ...... sing in renal transplantation.
@ast
The CLEAR study: a 5-day, 3-g ...... sing in renal transplantation.
@en
P2093
P2860
P356
P1476
The CLEAR study: a 5-day, 3-g ...... sing in renal transplantation.
@en
P2093
Ahmed Shoker
Azemi A Barama
Bryce A Kiberd
Carl J Cardella
David Landsberg
Isabelle Houde
Lidia Pirc
Michelle M Wrobel
Paul A Keown
Raymond Dandavino
P2860
P304
P356
10.2215/CJN.09091209
P577
2010-05-24T00:00:00Z